BIO-TECHNE Corp Operating Cash Flow
BIO-TECHNE Corp (TECH) reported Operating Cash Flow of $292.07 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-24
- BIO-TECHNE Corp net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $95.42M, a 2.84% decline year-over-year.
- BIO-TECHNE Corp net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $86.66M, a 110.75% increase year-over-year.
- BIO-TECHNE Corp net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $82.41M, a 2.29% decline year-over-year.
- BIO-TECHNE Corp net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $27.59M, a 56.82% decline year-over-year.
- BIO-TECHNE Corp net cash provided by (used in) operating activities for fiscal 2026 was $292.07M, a 1.57% increase from fiscal 2025.
- BIO-TECHNE Corp net cash provided by (used in) operating activities for fiscal 2025 was $287.56M, a 3.82% decline from fiscal 2024.
- BIO-TECHNE Corp net cash provided by (used in) operating activities for fiscal 2024 was $298.98M, a 17.53% increase from fiscal 2023.
- BIO-TECHNE Corp net cash provided by (used in) operating activities for fiscal 2023 was $254.39M, a 21.79% decline from fiscal 2022.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $95.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $182.08M derived: sum of 2 quarters · filed 2026-08-24 | $264.49M derived: sum of 3 quarters · filed 2026-08-24 | $292.07M 10-K · filed 2026-08-24 |
| 2026-03-31 | $86.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | $169.07M derived: sum of 2 quarters · filed 2026-05-06 | $196.66M 10-Q · filed 2026-05-06 | $294.86M derived: sum of 4 quarters · filed 2026-08-24 |
| 2025-12-31 | $82.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | $110.00M 10-Q · filed 2026-02-04 | $208.20M derived: sum of 3 quarters · filed 2026-08-24 | $249.32M derived: sum of 4 quarters · filed 2026-08-24 |
| 2025-09-30 | $27.59M 10-Q · filed 2025-11-05 | $125.79M derived: sum of 2 quarters · filed 2026-08-24 | $166.91M derived: sum of 3 quarters · filed 2026-08-24 | $251.25M derived: sum of 4 quarters · filed 2026-08-24 |
| 2025-06-30 | $98.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $139.32M derived: sum of 2 quarters · filed 2026-08-24 | $223.67M derived: sum of 3 quarters · filed 2026-08-24 | $287.56M 10-K · filed 2026-08-24 |
| 2025-03-31 | $41.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | $125.47M derived: sum of 2 quarters · filed 2026-05-06 | $189.35M 10-Q · filed 2026-05-06 | $264.85M derived: sum of 4 quarters · filed 2026-08-24 |
| 2024-12-31 | $84.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | $148.24M 10-Q · filed 2026-02-04 | $223.73M derived: sum of 3 quarters · filed 2026-08-24 | $304.72M derived: sum of 4 quarters · filed 2026-08-24 |
| 2024-09-30 | $63.89M 10-Q · filed 2025-11-05 | $139.38M derived: sum of 2 quarters · filed 2026-08-24 | $220.37M derived: sum of 3 quarters · filed 2026-08-24 | $303.49M derived: sum of 4 quarters · filed 2026-08-24 |
| 2024-06-30 | $75.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $156.48M derived: sum of 2 quarters · filed 2026-08-24 | $239.60M derived: sum of 3 quarters · filed 2026-08-24 | $298.98M 10-K · filed 2026-08-24 |
| 2024-03-31 | $80.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-08 | $164.10M derived: sum of 2 quarters · filed 2025-05-08 | $223.49M 10-Q · filed 2025-05-08 | $306.88M derived: sum of 4 quarters · filed 2025-08-22 |
| 2023-12-31 | $83.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-06 | $142.50M 10-Q · filed 2025-02-06 | $225.89M derived: sum of 3 quarters · filed 2025-08-22 | $276.43M derived: sum of 4 quarters · filed 2025-08-22 |
| 2023-09-30 | $59.38M 10-Q · filed 2024-11-05 | $142.78M derived: sum of 2 quarters · filed 2025-08-22 | $193.31M derived: sum of 3 quarters · filed 2025-08-22 | $257.69M derived: sum of 4 quarters · filed 2025-08-22 |
| 2023-06-30 | $83.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | $133.93M derived: sum of 2 quarters · filed 2025-08-22 | $198.31M derived: sum of 3 quarters · filed 2025-08-22 | $254.39M 10-K · filed 2025-08-22 |
| 2023-03-31 | $50.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-06 | $114.92M derived: sum of 2 quarters · filed 2024-05-06 | $171.00M 10-Q · filed 2024-05-06 | $273.72M derived: sum of 4 quarters · filed 2024-08-22 |
| 2022-12-31 | $64.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-07 | $120.47M 10-Q · filed 2024-02-07 | $223.18M derived: sum of 3 quarters · filed 2024-08-22 | $296.31M derived: sum of 4 quarters · filed 2024-08-22 |
| 2022-09-30 | $56.08M 10-Q · filed 2023-11-07 | $158.80M derived: sum of 2 quarters · filed 2024-08-22 | $231.93M derived: sum of 3 quarters · filed 2024-08-22 | $332.92M derived: sum of 4 quarters · filed 2024-08-22 |
| 2022-06-30 | $102.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22 | $175.84M derived: sum of 2 quarters · filed 2024-08-22 | $276.84M derived: sum of 3 quarters · filed 2024-08-22 | $325.27M 10-K · filed 2024-08-22 |
| 2022-03-31 | $73.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-08 | $174.12M derived: sum of 2 quarters · filed 2023-05-08 | $222.56M 10-Q · filed 2023-05-08 | $344.57M derived: sum of 4 quarters · filed 2023-08-23 |
| 2021-12-31 | $100.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07 | $149.43M 10-Q · filed 2023-02-07 | $271.45M derived: sum of 3 quarters · filed 2023-08-23 | $346.31M derived: sum of 4 quarters · filed 2023-08-23 |
| 2021-09-30 | $48.43M 10-Q · filed 2022-11-07 | $170.45M derived: sum of 2 quarters · filed 2023-08-23 | $245.32M derived: sum of 3 quarters · filed 2023-08-23 | $334.59M derived: sum of 4 quarters · filed 2023-08-23 |
| 2021-06-30 | $122.02M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $196.89M derived: sum of 2 quarters · filed 2023-08-23 | $286.15M derived: sum of 3 quarters · filed 2023-08-23 | $352.16M 10-K · filed 2023-08-23 |
| 2021-03-31 | $74.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-09 | $164.13M derived: sum of 2 quarters · filed 2022-05-09 | $230.14M 10-Q · filed 2022-05-09 | $274.94M derived: sum of 4 quarters · filed 2022-08-24 |
| 2020-12-31 | $89.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-07 | $155.28M 10-Q · filed 2022-02-07 | $200.07M derived: sum of 3 quarters · filed 2022-08-24 | $249.54M derived: sum of 4 quarters · filed 2022-08-24 |
| 2020-09-30 | $66.01M 10-Q · filed 2021-11-08 | $66.01M 10-Q · filed 2020-11-09 | $160.27M derived: sum of 3 quarters · filed 2022-08-24 | $230.69M derived: sum of 4 quarters · filed 2022-08-24 |
| 2020-06-30 | $44.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-24 | $94.26M derived: sum of 2 quarters · filed 2022-08-24 | $164.68M derived: sum of 3 quarters · filed 2022-08-24 | $205.22M 10-K · filed 2022-08-24 |
| 2020-03-31 | $49.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-07 | $119.89M derived: sum of 2 quarters · filed 2021-05-07 | $160.43M 10-Q · filed 2021-05-07 | $216.37M derived: sum of 4 quarters · filed 2021-08-25 |
| 2019-12-31 | $70.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-08 | $110.96M 10-Q · filed 2021-02-08 | $166.90M derived: sum of 3 quarters · filed 2021-08-25 | $206.56M derived: sum of 4 quarters · filed 2021-08-25 |
| 2019-09-30 | $40.54M 10-Q · filed 2019-11-06 | $40.54M 10-Q · filed 2020-11-09 | $136.15M derived: sum of 3 quarters · filed 2021-08-25 | $182.71M derived: sum of 4 quarters · filed 2021-08-25 |
| 2019-06-30 | $55.95M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25 | $95.61M derived: sum of 2 quarters · filed 2021-08-25 | $142.17M derived: sum of 3 quarters · filed 2021-08-25 | $181.62M 10-K · filed 2021-08-25 |
| 2019-03-31 | $39.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | $86.22M derived: sum of 2 quarters · filed 2020-05-11 | $125.67M 10-Q · filed 2020-05-11 | $190.51M derived: sum of 4 quarters · filed 2020-08-26 |
| 2018-12-31 | $46.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | $86.01M 10-Q · filed 2020-02-06 | $150.85M derived: sum of 3 quarters · filed 2020-08-26 | $172.50M derived: sum of 4 quarters · filed 2020-08-26 |
| 2018-09-30 | $39.45M 10-Q · filed 2019-11-06 | $104.29M derived: sum of 2 quarters · filed 2020-08-26 | $125.94M derived: sum of 3 quarters · filed 2020-08-26 | $165.12M derived: sum of 4 quarters · filed 2020-08-26 |
| 2018-06-30 | $64.84M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-26 | $86.49M derived: sum of 2 quarters · filed 2020-08-26 | $125.67M derived: sum of 3 quarters · filed 2020-08-26 | $170.37M 10-K · filed 2020-08-26 |
| 2018-03-31 | $21.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-07 | $60.83M derived: sum of 2 quarters · filed 2019-05-07 | $105.53M 10-Q · filed 2019-05-07 | $156.38M derived: sum of 4 quarters · filed 2019-11-06 |
| 2017-12-31 | $39.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07 | $83.88M 10-Q · filed 2019-02-07 | $134.73M derived: sum of 3 quarters · filed 2019-11-06 | $159.75M derived: sum of 4 quarters · filed 2019-11-06 |
| 2017-09-30 | $44.70M 10-Q · filed 2018-11-07 | $95.54M derived: sum of 2 quarters · filed 2019-11-06 | $44.70M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $50.85M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06 | $75.87M derived: sum of 2 quarters · filed 2019-11-06 | $143.72M 10-K/A · filed 2019-11-06 | |
| 2017-03-31 | $25.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $92.87M 10-Q · filed 2018-05-09 | ||
| 2016-12-31 | $67.85M 10-Q · filed 2018-02-08 | |||
| 2016-09-30 | $26.22M 10-Q · filed 2017-11-09 | |||
| 2016-06-30 | $144.16M 10-K · filed 2018-08-27 | |||
| 2014-03-31 | $34.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-12 | $66.26M derived: sum of 2 quarters · filed 2014-05-12 | $98.84M 10-Q · filed 2014-05-12 | $128.83M derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-12-31 | $31.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-04 | $63.91M 10-Q · filed 2014-02-04 | $93.89M derived: sum of 3 quarters · filed 2014-02-04 | $126.92M derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-09-30 | $32.59M 10-Q · filed 2013-11-12 | $62.57M derived: sum of 2 quarters · filed 2013-11-12 | $95.60M derived: sum of 3 quarters · filed 2014-05-12 | $126.88M derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-06-30 | $29.99M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29 | $63.01M derived: sum of 2 quarters · filed 2014-05-12 | $94.30M derived: sum of 3 quarters · filed 2014-05-12 | $123.56M 10-K · filed 2013-08-29 |
| 2013-03-31 | $33.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-12 | $64.31M derived: sum of 2 quarters · filed 2014-05-12 | $93.58M 10-Q · filed 2014-05-12 | $130.99M derived: sum of 4 quarters · filed 2014-05-12 |
| 2012-12-31 | $31.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-04 | $60.55M 10-Q · filed 2014-02-04 | $97.96M derived: sum of 3 quarters · filed 2014-02-04 | $132.43M derived: sum of 4 quarters · filed 2014-02-04 |
| 2012-09-30 | $29.26M 10-Q · filed 2013-11-12 | $66.68M derived: sum of 2 quarters · filed 2013-11-12 | $101.14M derived: sum of 3 quarters · filed 2013-11-12 | $121.58M derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-06-30 | $37.41M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29 | $71.88M derived: sum of 2 quarters · filed 2013-08-29 | $92.31M derived: sum of 3 quarters · filed 2013-08-29 | $126.75M 10-K · filed 2013-08-29 |
| 2012-03-31 | $34.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-10 | $54.90M derived: sum of 2 quarters · filed 2013-05-10 | $89.33M 10-Q · filed 2013-05-10 | $124.00M derived: sum of 4 quarters · filed 2013-08-29 |
| 2011-12-31 | $20.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-11 | $54.87M 10-Q · filed 2013-02-11 | $89.54M derived: sum of 3 quarters · filed 2013-08-29 | $121.93M derived: sum of 4 quarters · filed 2013-08-29 |
| 2011-09-30 | $34.43M 10-Q · filed 2012-11-09 | $69.10M derived: sum of 2 quarters · filed 2013-08-29 | $101.49M derived: sum of 3 quarters · filed 2013-08-29 | $130.92M derived: sum of 4 quarters · filed 2013-08-29 |
| 2011-06-30 | $34.67M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29 | $67.06M derived: sum of 2 quarters · filed 2013-08-29 | $96.49M derived: sum of 3 quarters · filed 2013-08-29 | $127.19M 10-K · filed 2013-08-29 |
| 2011-03-31 | $32.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-10 | $61.82M derived: sum of 2 quarters · filed 2012-05-10 | $92.52M 10-Q · filed 2012-05-10 | $124.30M derived: sum of 4 quarters · filed 2012-08-29 |
| 2010-12-31 | $29.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-07 | $60.14M 10-Q · filed 2012-02-07 | $91.92M derived: sum of 3 quarters · filed 2012-08-29 | $115.13M derived: sum of 4 quarters · filed 2012-08-29 |
| 2010-09-30 | $30.70M 10-Q · filed 2011-11-09 | $62.48M derived: sum of 2 quarters · filed 2012-08-29 | $85.70M derived: sum of 3 quarters · filed 2012-08-29 | $113.93M derived: sum of 4 quarters · filed 2012-08-29 |
| 2010-06-30 | $31.78M derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-29 | $55.00M derived: sum of 2 quarters · filed 2012-08-29 | $83.23M derived: sum of 3 quarters · filed 2012-08-29 | $111.26M 10-K · filed 2012-08-29 |
| 2010-03-31 | $23.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-05-10 | $51.45M derived: sum of 2 quarters · filed 2011-05-10 | $79.48M 10-Q · filed 2011-05-10 | |
| 2009-12-31 | $28.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-02-09 | $56.26M 10-Q · filed 2011-02-09 | ||
| 2009-09-30 | $28.03M 10-Q · filed 2010-11-09 | |||
| 2009-06-30 | $111.32M 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |